<DOC>
	<DOCNO>NCT00866034</DOCNO>
	<brief_summary>Rationale : In daily practice fertility treatment increasingly patient focus innovative medication standardize treatment guideline develop improve patient convenience . GnRH antagonist cotreatment prevent premature luteinization ovarian stimulation IVF ICSI greatly reduce burden treatment , partly reduce number injection around 21 compare optimal GnRH agonist 'long ' protocol . However , optimal GnRH antagonist protocol still know . There number reason suggest simplicity treatment clinical outcome could improve commence GnRH antagonist treatment day ovarian stimulation start . These include synchronized follicle development reduce rate premature luteinization . This study investigate whether novel early fix start protocol improve outcomes comparison widely employ late fix start protocol . Objective : To demonstrate whether early fix start antagonist protocol improve live birth rate compare late fix start antagonist protocol 5 % . Study design : Prospective , multicenter , investigator sponsor , randomize control trial Study population : - Normo-ovulatory woman &lt; 39 year indication IVF ICSI - No 2 previous unsuccessful IVF/ICSI cycle - BMI â‰¤ 32 kg/m2 Intervention : Two different GnRH antagonist treatment protocol use daily practice compare . Patients randomize receive one follow two treatment : - Early fixed start : start GnRH antagonist treatment Cetrotide 0.25 mg day FSH , cycle day 2 . - Late fixed start : FSH administer cycle day 2 . GnRH antagonist treatment Cetrotide 0.25 mg commence cycle day 6 . Main study parameters/endpoints : The primary endpoint live birth rate per start cycle . A secondary endpoint number embryo available transfer . Nature extent burden risk associate participation , benefit group relatedness : In addition record clinical outcome , endocrine study carry UMC Utrecht sample 200 participant subject blood sample three point treatment cycle : prior commence treatment cycle day 2 , cycle day 6 day hCG administration.The aim substudy therefore prospectively compare effect cycle day 2 versus cycle day 6 fixed start GnRH antagonist protocol LH , estradiol progesterone level mid late follicular phase . In order investigate whether early fix protocol exerts significant extra burden patient compare late start protocol , another group 200 participant UMCU request complete HADS questionnaire ( Hospital Anxiety Depression Scale ) .</brief_summary>
	<brief_title>Cetrotide Treatment Optimization</brief_title>
	<detailed_description />
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>Normoovulatory woman &lt; 39 year indication IVF ICSI More 2 previous unsuccessful IVF/ICSI cycle BMI &gt; 32 kg/m2</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Cetrotide</keyword>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
	<keyword>Treatment protocol</keyword>
</DOC>